Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

EF Hutton Reiterates Buy on GH Research, Maintains $33 Price Target

EF Hutton analyst Elemer Piros reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $33 price target.
byBenzinga Newsdesk
March 2, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

EF Hutton analyst Elemer Piros reiterates GH Research (NASDAQ:GHRS) with a Buy and maintains $33 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cerevel Reports Results In Emraclidine Ambulatory Blood Pressure Monitoring Trial; Co. Reports ‘Data provide clear evidence that emraclidine does not induce an increase in blood pressure with chronic dosing in people living with schizophrenia’

By Benzinga Newsdesk
December 19, 7:32 AM
Data provide clear evidence that emraclidine does not induce an increase in blood pressure with chronic dosing in people living with schizophrenia Emraclidine demonstrated a mean change from baseline in 24-hour

CERE